23 May 2013
Keywords: amarillo, hep, agent, cleared, ph, ii, taiwan
Article | 23 February 2009
Texas, USA-based Amarillo Biosciences says that the Taiwanese Department of Health has approved an application to test its low-dose oral
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2009
© 2013 thepharmaletter.com